Follow
Louis Maes
Louis Maes
Gewoon Hoogleraar, Universiteit Antwerpen
Verified email at uantwerpen.be
Title
Cited by
Cited by
Year
Guidelines for the treatment of malaria
World Health Organization
World Health Organization, 2015
6458*2015
Anti-infective potential of natural products: How to develop a stronger in vitro ‘proof-of-concept’
P Cos, AJ Vlietinck, DV Berghe, L Maes
Journal of ethnopharmacology 106 (3), 290-302, 2006
21262006
Quorum sensing inhibitors increase the susceptibility of bacterial biofilms to antibiotics in vitro and in vivo
G Brackman, P Cos, L Maes, HJ Nelis, T Coenye
Antimicrobial agents and chemotherapy 55 (6), 2655-2661, 2011
6172011
Leishmania–macrophage interactions: Insights into the redox biology
T Van Assche, M Deschacht, RAI da Luz, L Maes, P Cos
Free Radical Biology and Medicine 51 (2), 337-351, 2011
3012011
Open source drug discovery with the malaria box compound collection for neglected diseases and beyond
WC Van Voorhis, JH Adams, R Adelfio, V Ahyong, MH Akabas, P Alano, ...
PLoS pathogens 12 (7), e1005763, 2016
2912016
In Vitro Susceptibilities of Leishmania donovani Promastigote and Amastigote Stages to Antileishmanial Reference Drugs: Practical Relevance of Stage-Specific …
M Vermeersch, RI da Luz, K Toté, JP Timmermans, P Cos, L Maes
Antimicrobial agents and chemotherapy 53 (9), 3855-3859, 2009
2812009
Extended structure–activity relationship and pharmacokinetic investigation of (4-quinolinoyl) glycyl-2-cyanopyrrolidine inhibitors of fibroblast activation protein (FAP)
K Jansen, L Heirbaut, R Verkerk, JD Cheng, J Joossens, P Cos, L Maes, ...
Journal of medicinal chemistry 57 (7), 3053-3074, 2014
2012014
Advancing drug innovation for neglected diseases—criteria for lead progression
S Nwaka, B Ramirez, R Brun, L Maes, F Douglas, R Ridley
PLoS neglected tropical diseases 3 (8), e440, 2009
1992009
Inhibitory Effect of Biocides on the Viable Masses and Matrices of Staphylococcus aureus and Pseudomonas aeruginosa Biofilms
K Toté, T Horemans, DV Berghe, L Maes, P Cos
Applied and environmental microbiology 76 (10), 3135-3142, 2010
1922010
Biofilms: an extra hurdle for effective antimicrobial therapy
P Cos, K Tote, T Horemans, L Maes
Current pharmaceutical design 16 (20), 2279-2295, 2010
1882010
A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline
E Davioud-Charvet, S Delarue, C Biot, B Schwöbel, CC Boehme, ...
Journal of medicinal chemistry 44 (24), 4268-4276, 2001
1832001
PLGA nanoparticles and nanosuspensions with amphotericin B: potent in vitro and in vivo alternatives to Fungizone and AmBisome
H Van de Ven, C Paulussen, PB Feijens, A Matheeussen, P Rombaut, ...
Journal of controlled release 161 (3), 795-803, 2012
1812012
Plant substances as anti-HIV agents selected according to their putative mechanism of action
P Cos, L Maes, D Vanden Berghe, N Hermans, L Pieters, A Vlietinck
Journal of Natural Products 67 (2), 284-293, 2004
1812004
Synthesis, cytotoxicity, and antiplasmodial and antitrypanosomal activity of new neocryptolepine derivatives
THM Jonckers, S Van Miert, K Cimanga, C Bailly, P Colson, ...
Journal of Medicinal Chemistry 45 (16), 3497-3508, 2002
1782002
Selective inhibitors of fibroblast activation protein (FAP) with a (4-quinolinoyl)-glycyl-2-cyanopyrrolidine scaffold
K Jansen, L Heirbaut, JD Cheng, J Joossens, O Ryabtsova, P Cos, ...
ACS medicinal chemistry letters 4 (5), 491-496, 2013
1752013
Antimalarial, antitrypanosomal, and antileishmanial activities and cytotoxicity of bis (9-amino-6-chloro-2-methoxyacridines): influence of the linker
S Girault, P Grellier, A Berecibar, L Maes, E Mouray, P Lemiere, ...
Journal of medicinal chemistry 43 (14), 2646-2654, 2000
1682000
Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent
H Imamura, T Downing, F Van den Broeck, MJ Sanders, S Rijal, S Sundar, ...
Elife 5, e12613, 2016
1602016
Synthesis and in Vitro and in Vivo Antimalarial Activity of N-(7-Chloro-4-quinolyl)-1, 4-bis (3-aminopropyl) piperazine Derivatives
A Ryckebusch, R Deprez-Poulain, L Maes, MA Debreu-Fontaine, ...
Journal of medicinal chemistry 46 (4), 542-557, 2003
1562003
Structure-activity relationship of cinnamaldehyde analogs as inhibitors of AI-2 based quorum sensing and their effect on virulence of Vibrio spp
G Brackman, S Celen, U Hillaert, S Van Calenbergh, P Cos, L Maes, ...
PLoS One 6 (1), e16084, 2011
1482011
Plant-derived leading compounds for chemotherapy of human immunodefiency virus (HIV) infection–an update (1998–2007)
P Cos, L Maes, A Vlietinck, L Pieters
Planta Medica, 1323-1337, 2008
1462008
The system can't perform the operation now. Try again later.
Articles 1–20